Comparing Two Preventive Regimens for Latent Tuberculosis Infection (LTBI)
Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
Though still an endemic area, the incidence of tuberculosis (TB) in Taiwan is decreasing in
recent years. Further reduction in TB incidence, or even elimination should rely on treatment
for LTBI. However, which is the cost-effective screening method or what is the cost-effective
regimen in Taiwan is still unclear.
Therefore, the investigators designed this prospective study to follow up adult household
contacts with LTBI for 2 years and compare the efficacy of 9-month isoniazid and 4-month
rifampicin).